Unlock the Power of Biomedical Data with the R2 Platform

In today's rapidly evolving landscape of biomedical research, access to high-quality, well-curated data is paramount. Researchers and clinicians alike are constantly seeking efficient ways to explore, analyze, and ultimately translate complex biological information into tangible advancements in patient care. Enter the R2 Platform (r2.amc.nl) – your gateway to a wealth of expertly managed biomedical data.

Developed and maintained by Amsterdam UMC, the R2 platform stands as a robust and user-friendly resource designed to empower your research endeavors. Whether you're a seasoned bioinformatician, a dedicated clinician, or a curious researcher venturing into the world of biomedical data, R2 offers a comprehensive suite of tools and datasets to fuel your discoveries.

What makes the R2 Platform stand out?

  • Curated and Integrated Datasets: Tired of sifting through disparate data sources? R2 brings together a diverse collection of meticulously curated and integrated datasets, spanning genomics, transcriptomics, proteomics and clinical information. This centralized approach saves you valuable time and effort, allowing you to focus on what truly matters – your research questions.
  • Intuitive and User-Friendly Interface: Navigating complex data has never been easier. R2 boasts an intuitive and well-designed interface that requires no advanced programming skills. Explore datasets, visualize results, and perform basic analyses with just a few clicks.
  • Powerful Analytical Tools: Go beyond simple data exploration. R2 integrates a range of powerful analytical tools, enabling you to perform statistical analyses, generate insightful visualizations, and identify meaningful patterns within the data.
  • Focus on Translational Research: R2 is built with the ultimate goal of translating research findings into tangible benefits for patients. The platform facilitates the connection between basic science discoveries and clinical applications, fostering innovation in diagnostics, prognostics, and therapeutics.
  • Expert Support and Community: The R2 platform is backed by a dedicated team of experts who provide comprehensive support and guidance. Furthermore, you become part of a vibrant community of researchers and clinicians who utilize the platform, fostering collaboration and knowledge sharing.
  • Secure and Compliant: We understand the sensitive nature of biomedical data. The R2 platform adheres to the highest security and compliance standards, ensuring the privacy and integrity of all data.

Who can benefit from the R2 Platform?

  • Biomedical Researchers: Accelerate your discoveries by accessing a wealth of integrated data and powerful analytical tools.
  • Clinicians: Gain deeper insights into disease mechanisms, identify potential biomarkers, and personalize treatment strategies.
  • Bioinformaticians: Streamline your data analysis workflows and leverage a well-structured and curated data environment.
  • Pharmaceutical and Biotechnology Companies: Identify novel drug targets, optimize clinical trial design, and accelerate drug development.



Ready to unlock the power of biomedical data?

Visit r2.amc.nl today to explore the platform and discover how it can revolutionize your research. Browse our available datasets, explore our analytical tools, and join a thriving community dedicated to advancing biomedical knowledge.

Explore R2 Platform Now

The R2 Platform – Empowering Biomedical Discovery, Driving Patient Impact.

Developed and maintained by Amsterdam UMC.

Comments

Post a Comment

Popular posts from this blog

R2: An Interactive Online Portal for Tumor Subgroup Gene Expression and Survival Analyses, Intended for Biomedical Researchers

Image
  R2: An Interactive Online Portal for Tumor Subgroup Gene Expression and Survival Analyses, Intended for Biomedical Researchers Genomic data from The Cancer Genome Atlas (TCGA) project has enabled comprehensive molecular profiling of diverse cancer types. The extensive sample size within TCGA provides an invaluable resource for investigating tumor heterogeneity. Effective exploration of this dataset by researchers and clinicians is essential for discovering novel therapeutic and diagnostic biomarkers. While numerous computational tools have been developed to analyze specific aspects of TCGA data, there remains a need for platforms that facilitate the study of gene expression variability and its association with clinical outcomes across tumors. Here, we introduce the  R2 Platform , an intuitive and interactive web portal designed for in-depth analysis of TCGA gene expression data. The portal leverages TCGA Level 3 RNA-seq and clinical data from 31 cancer types. With its user-f...
Read more

Create a visual Fisher's Exact plot in a few simple clicks in the R2 Genomics Analysis & Visualization platform

Image
Create a visual Fisher's Exact plot in a few simple clicks in the R2 Genomics Analysis & Visualization platform ( https://r2.amc.nl ). Just see the whole process in action in the illustration below. The Fisher's Exact test is often used to demonstrate whether the proportions of 2 different categorical variables are equal to the expectation. A significant p-value then informs you that this is unlikely (when used as a 2-sided test). Within R2, we add a visual element to such a test, where you can see the different groups in the contingency table as separate dots. These dots, are linked to actual samples in the data set, and can thus also be decorated using their meta data (color by a grouping variable), or even by the expression of any gene. As such you can add another layer in your interpretation. Just have a look at the animation above on how you can easily use this powerful option within the R2platform. The R2 open access online data science platform, designed for biomedic...
Read more

TCGA Barcodes (Sample Types)

Image
The Cancer Genome Atlas Program (TCGA) is one of the cornerstones of cancer research. Every sample has a unique identifier, also known as barcode. A basic understanding of the naming convention is very helpful to quickly assess the 'type of sample' that you are working with. The sample type is contained in the numerical part of the 4th element of a barcode, that can be up to 7 parts. Barcodes most commonly are composed of 4 parts, which is informative for most use cases. Code Definition 1 Primary Solid Tumor 2 Recurrent Solid Tumor 3 Primary Blood Derived Cancer - Peripheral Blood 4 Recurrent Blood Derived Cancer - Bone Marrow 5 Additional - New Primary 6 Metastatic 7 Additional Metastatic 8 Human Tumor Original Cells 9 Primary Blood Derived Cancer - Bone Marrow 10 Blood Derived Normal 11 Solid Tissue Normal 12 Buccal Cell Normal 13 EBV Immortalized Normal 14 Bone Marrow Normal 15 sample type 15 16 sample type 16 20 Control Analyte 40 Recur...
Read more